1. Home
  2. Detail

@buang_kuy: Yang butuh Kertas Struk Printer Mini dari Woya hasilnya sangat tajam,#kertasprinter #mesinedc #tokopembayaran #printerthermal

buang_kuy
buang_kuy
Open In TikTok:
Region: ID
Monday 15 September 2025 09:44:06 GMT
4729
6
0
50

Music

Download

No Watermark .mp4 (5.65MB) No Watermark(HD) .mp4 (5.65MB) Watermark .mp4 (5.82MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @buang_kuy, please go to the Tikwm homepage.

Other Videos
Messi retired from international football💔 Thanks for everything Leo🙏🏼 #edit #football #messi #argentina #lionelmessi messi // lionel messi // messi retirement // messi retired // messi international retirement // argentina // argentina edit // messi edit //
Messi retired from international football💔 Thanks for everything Leo🙏🏼 #edit #football #messi #argentina #lionelmessi messi // lionel messi // messi retirement // messi retired // messi international retirement // argentina // argentina edit // messi edit //
البعض سيصفه غباء والبعض يعتبره تكبر والبعض القليل سيرى الحكمة في ذلك ، لسنا آلات لنقوم بنسخ كل شيء مطلوب منا دون تفكير ، طبعا انا ما اقصد الصلاه وهذا الفيديو ما مقصود منه شيء #كتاباتي #كتابات #اقتباسات #فصحة
البعض سيصفه غباء والبعض يعتبره تكبر والبعض القليل سيرى الحكمة في ذلك ، لسنا آلات لنقوم بنسخ كل شيء مطلوب منا دون تفكير ، طبعا انا ما اقصد الصلاه وهذا الفيديو ما مقصود منه شيء #كتاباتي #كتابات #اقتباسات #فصحة
Standard CBC and CMP panels measure about 20 things and were designed in the mid 20th century to catch acute pathology. They don’t measure complement activation, cytokine networks, or the proteomic signatures of chronic immune dysregulation. The technology to measure thousands of proteins at once only became commercially viable around 2019, which is why paradigm-shifting research like this is happening now and not decades ago. A 2024 study by Cervia-Hasler et al. in Science used SomaScan proteomics on 113 long COVID patients and 39 controls. They identified persistent complement dysregulation including C7 complexes and terminal complement, plus markers of red blood cell injury and platelet activation. Almost none of these show up on routine bloodwork. A 2025 Nature Immunology study by Gao et al. replicated this in independent Swedish and UK cohorts and found multiple distinct biomarker signatures mapping to different long COVID symptom clusters. This kind of unbiased proteomic testing is not yet standard clinical care, and the assays used are not commercially available to the average patient. The findings need further replication and standardization before changing how chronic illness is diagnosed. The research does not say standard labs are useless. They are still essential for catching acute pathology. The point is they were never designed to catch chronic immune dysregulation. I’m not a doctor, just sharing research I find interesting. Sources: Cervia-Hasler et al. (2024). Persistent complement dysregulation with signs of thromboinflammation in active long COVID. Science. DOI: 10.1126/science.adg7942 Gao et al. (2025). Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nature Immunology. DOI: 10.1038/s41590-025-02135-5 #chronicillness #immunesystem #inflammation #medicalgaslighting
Standard CBC and CMP panels measure about 20 things and were designed in the mid 20th century to catch acute pathology. They don’t measure complement activation, cytokine networks, or the proteomic signatures of chronic immune dysregulation. The technology to measure thousands of proteins at once only became commercially viable around 2019, which is why paradigm-shifting research like this is happening now and not decades ago. A 2024 study by Cervia-Hasler et al. in Science used SomaScan proteomics on 113 long COVID patients and 39 controls. They identified persistent complement dysregulation including C7 complexes and terminal complement, plus markers of red blood cell injury and platelet activation. Almost none of these show up on routine bloodwork. A 2025 Nature Immunology study by Gao et al. replicated this in independent Swedish and UK cohorts and found multiple distinct biomarker signatures mapping to different long COVID symptom clusters. This kind of unbiased proteomic testing is not yet standard clinical care, and the assays used are not commercially available to the average patient. The findings need further replication and standardization before changing how chronic illness is diagnosed. The research does not say standard labs are useless. They are still essential for catching acute pathology. The point is they were never designed to catch chronic immune dysregulation. I’m not a doctor, just sharing research I find interesting. Sources: Cervia-Hasler et al. (2024). Persistent complement dysregulation with signs of thromboinflammation in active long COVID. Science. DOI: 10.1126/science.adg7942 Gao et al. (2025). Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nature Immunology. DOI: 10.1038/s41590-025-02135-5 #chronicillness #immunesystem #inflammation #medicalgaslighting
الأول
الأول
#عقد_قران #عقد_قران_أختي #اكسبلورexplore #الشعب_الصيني_ماله_حل😂😂 #viral
#عقد_قران #عقد_قران_أختي #اكسبلورexplore #الشعب_الصيني_ماله_حل😂😂 #viral

About

Legal